Breadcrumb

What's New at the RI-MUHC ?

When RSV weighs heavily on the Canadian health-care system

The adoption of preventive measures could alleviate this burden, shows a study carried out by researchers at the Montreal Children's Hospital and...

Major scientific achievement gives hope to families affected by 4H leukodystrophy

RI-MUHC team creates first representative model of this rare disease

Severe maternal complications at childbirth: a recurring hazard?

New study paints clear picture of maternal health within the population of Quebec

More than 75% of Canadians had immunity to SARS-CoV-2 due to infection by March 2023

Scientists used aggregate data to estimate trends in both infection-acquired and vaccine-induced...

Medical writing: caution warranted if using ChatGPT

Researchers from CHU Sainte-Justine and the Montreal Children's Hospital recently asked ChatGPT 20 medical questions...

New understanding of processes involved in breast cancer metastasis

A study led by RI-MUHC researcher Nathalie Lamarche-Vane reveals the mechanisms underlying regulation...

Unravelling mechanisms for cardiovascular therapeutics

RI-MUHC researchers co-lead a team that combines novel pharmacology with structural biology and computational modelling to discover new domains...

All airway trees are not created equal

An RI-MUHC study suggests that lung development in early life has an impact on the risk of premature death

World-first clinical trial to help millions of people with penicillin allergies

The PALACE study, an international research endeavour, has evaluated a safer and simpler approach to penicillin allergy testing

New research aims to make prostate cancer prognostics more precise

A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer

Learn more about the RI-MUHC